Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Psilocybin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Interventions

Cyclophosphamide 12 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 9 Busulfan 9 Biopsy 9 Whole-Body Irradiation 8 Surveys and Questionnaires 8 Polymerase Chain Reaction 7 Mycophenolic Acid 7 Tacrolimus 6 Gene Expression Profiling 6 Early Intervention, Educational 6 Colposcopy 6 fludarabine 5 Methotrexate 5 Melphalan 5 Educational Status 5 Decitabine 5 Cyclosporine 5 Celecoxib 5 Carboplatin 5 Antilymphocyte Serum 5 Aminolevulinic Acid 5 Sulindac 4 Radiotherapy 4 Patient Reported Outcome Measures 4 Paclitaxel 4 Microarray Analysis 4 Methods 4 Interviews as Topic 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡